Abstract
Introduction
The community deintensification rates in older people with diabetes are low and hospital admission presents an opportunity for medication review. We audited the inpatient assessment and deintensification rate in people with diabetes and frailty. We also identified factors associated with adverse inpatient outcomes.
Methods
A retrospective review of electronic charts was conducted in all people with diabetes and clinical frailty score ≥6 who were discharged from the medical unit in 2022. Data on demographics, comorbidities and background glucose-lowering medications were collected.
Results
Six-hundred-and-sixty-five people with diabetes and moderate/severe frailty were included in our analysis. For people with no HbA1c in the last six months preceding admission, only 9.0% had it assessed during inpatient. Deintensification rates were 19.1%. Factors that were associated with adverse inpatient outcomes included inpatient hypoglycaemia, non-White ethnicity, and being overtreated (HbA1c
| Original language | English |
|---|---|
| Article number | 100029 |
| Journal | Clinical Medicine |
| Early online date | 20 Feb 2024 |
| DOIs | |
| Publication status | E-pub ahead of print - 20 Feb 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- diabetes
- frailty
- quality improvment
- inpatient hypoglycaemia
Fingerprint
Dive into the research topics of 'Tertiary Centre Study Highlights Low Inpatient Deintensification and Risks Associated with Adverse Outcomes in Frail People with Diabetes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver